Prudential Financial Inc. decreased its position in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 38.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 204,590 shares of the company's stock after selling 126,120 shares during the period. Prudential Financial Inc. owned about 0.08% of Oscar Health worth $2,750,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of Oscar Health by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 18,997,973 shares of the company's stock worth $255,333,000 after buying an additional 586,626 shares during the period. State Street Corp lifted its stake in Oscar Health by 6.0% in the 3rd quarter. State Street Corp now owns 5,132,802 shares of the company's stock worth $108,867,000 after acquiring an additional 291,335 shares in the last quarter. Geode Capital Management LLC boosted its position in Oscar Health by 11.7% during the 3rd quarter. Geode Capital Management LLC now owns 4,339,640 shares of the company's stock worth $92,062,000 after acquiring an additional 455,205 shares during the period. Hennessy Advisors Inc. boosted its position in Oscar Health by 550.3% during the 4th quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company's stock worth $56,292,000 after acquiring an additional 3,544,300 shares during the period. Finally, Glynn Capital Management LLC grew its stake in Oscar Health by 42.7% during the 4th quarter. Glynn Capital Management LLC now owns 2,733,237 shares of the company's stock valued at $36,735,000 after acquiring an additional 817,518 shares in the last quarter. 75.70% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on the stock. Wells Fargo & Company lowered shares of Oscar Health from an "overweight" rating to an "equal weight" rating and reduced their price target for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Jefferies Financial Group started coverage on shares of Oscar Health in a report on Tuesday, December 10th. They set an "underperform" rating and a $12.00 price target on the stock. Two analysts have rated the stock with a sell rating, three have issued a hold rating, two have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $20.21.
Get Our Latest Stock Analysis on OSCR
Oscar Health Stock Down 3.8 %
Shares of OSCR traded down $0.50 during mid-day trading on Monday, hitting $12.51. 5,628,562 shares of the company's stock were exchanged, compared to its average volume of 3,810,658. The stock has a market cap of $3.13 billion, a price-to-earnings ratio of -624.94 and a beta of 1.75. The firm has a fifty day moving average of $14.53 and a two-hundred day moving average of $15.68. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a twelve month low of $11.89 and a twelve month high of $23.79.
Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. On average, sell-side analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current year.
About Oscar Health
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Stories
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
